These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 5243720

  • 21. [Quantitative studies of megakaryokinetics in chronic myeloproliferative disorders].
    Nagasawa T, Nakazawa M.
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):617-23. PubMed ID: 3166570
    [No Abstract] [Full Text] [Related]

  • 22. Platelet defects in the myeloproliferative disorders.
    Inceman S, Tangün Y.
    Ann N Y Acad Sci; 1972 Oct 27; 201():251-61. PubMed ID: 4509685
    [No Abstract] [Full Text] [Related]

  • 23. [Studies of the kinetics of normal and pathological granulopoiesis with radioactive diisopropylfluorophosphate].
    Nowotny P, Konrad H, Preussner S, Kiencke H.
    Z Gesamte Inn Med; 1970 May 01; 25(9):394-8. PubMed ID: 5289112
    [No Abstract] [Full Text] [Related]

  • 24. [Early diagnosis of proliferative bone-marrow diseases with radioactive iron].
    Montz R, Schneider C, Treske U.
    Dtsch Med Wochenschr; 1972 Jun 30; 97(26):994-1000. PubMed ID: 5038802
    [No Abstract] [Full Text] [Related]

  • 25. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
    Vilcu A, Hossu T, Popescu ID, Câmpeanu L.
    Med Interna (Bucur); 1973 Mar 30; 25(3):363-76. PubMed ID: 4527026
    [No Abstract] [Full Text] [Related]

  • 26. [Leukocyte alkaline phosphatase and glucose-6-phosphate-dehydrogenase of the erythrocytes in differential diagnosis of chronic myeloproliferative diseases (author's transl)].
    Hennemann HH, Schief A.
    Med Klin; 1974 Aug 23; 69(34):1359-63. PubMed ID: 4530151
    [No Abstract] [Full Text] [Related]

  • 27. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
    Epstein IS.
    Isr J Med Sci; 1965 Jul 23; 1(4):797-9. PubMed ID: 5892718
    [No Abstract] [Full Text] [Related]

  • 28. [The treatment of myelo-proliferative syndromes].
    Bousser J.
    Sem Ther; 1965 Jul 23; 41(6):349-52. PubMed ID: 5234604
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Patho-anatomical features of the bone marrow.
    Lennert K, Nagai K, Schwarze EW.
    Clin Haematol; 1975 Jun 23; 4(2):331-51. PubMed ID: 1102191
    [No Abstract] [Full Text] [Related]

  • 31. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
    Sayinalp N, Cinar H, Uner A, Haznedaroğlu IC, Büyükaşik Y, Göker H, Aksu S, Ozcebe OI, Karakuş S, Kirazli S, Dündar SV.
    Clin Lab Haematol; 2004 Aug 23; 26(4):265-8. PubMed ID: 15279663
    [Abstract] [Full Text] [Related]

  • 32. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
    Petrov MN, Vashkinel' VK.
    Probl Gematol Pereliv Krovi; 1977 May 23; 22(5):18-23. PubMed ID: 267283
    [No Abstract] [Full Text] [Related]

  • 33. [The treatment of myeloproliferative syndromes].
    Maurice P.
    Schweiz Med Wochenschr; 1975 Oct 04; 105(40):1269-74. PubMed ID: 1061995
    [Abstract] [Full Text] [Related]

  • 34. [Cytology and histology of the human bone marrow].
    Burkhardt R.
    Hamatol Bluttransfus; 1968 Oct 04; 4():11-29. PubMed ID: 5245346
    [No Abstract] [Full Text] [Related]

  • 35. Experimental and clinical megakaryocytopoiesis.
    Ebbe S.
    Clin Haematol; 1979 Jun 04; 8(2):371-94. PubMed ID: 158454
    [No Abstract] [Full Text] [Related]

  • 36. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
    Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, Pascutto C, Morra E, Lazzarino M, Cazzola M.
    Haematologica; 2003 Oct 04; 88(10):1123-9. PubMed ID: 14555308
    [Abstract] [Full Text] [Related]

  • 37. VARIATIONS OF HUMAN BLOOD CELL ZINC IN DISEASE.
    FREDRICKS RE, TANAKA KR, VALENTINE WN.
    J Clin Invest; 1964 Feb 04; 43(2):304-15. PubMed ID: 14162538
    [No Abstract] [Full Text] [Related]

  • 38. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D, Hasselbalch H, Knudsen JB.
    Scand J Clin Lab Invest; 1987 Sep 04; 47(5):497-501. PubMed ID: 3477851
    [Abstract] [Full Text] [Related]

  • 39. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H, Clemmensen I.
    Scand J Clin Lab Invest; 1987 Sep 04; 47(5):429-33. PubMed ID: 3477850
    [Abstract] [Full Text] [Related]

  • 40. STANDARDIZATION OF THE LEUKOCYTE ALKALINE PHOSPHATASE TEST. II. REPORT OF CLINICAL STUDIES.
    KNUDTSON KP, EVANGER AE, STEVENS AR.
    Am J Clin Pathol; 1964 Aug 04; 42():121-4. PubMed ID: 14202142
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.